Zobrazeno 1 - 10
of 969
pro vyhledávání: '"Paul J Martin"'
Autor:
Gideon Steinbach, David M Hockenbery, Gerwin Huls, Terry Furlong, David Myerson, Keith R Loeb, Jesse R Fann, Christina Castilla-Llorente, George B McDonald, Paul J Martin
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0183284 (2017)
Severe intestinal graft-vs-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT) causes mucosal ulceration and induces innate and adaptive immune responses that amplify and perpetuate GVHD and the associated barrier dysfunctio
Externí odkaz:
https://doaj.org/article/0591c512ca62400c97ffdd36bc9ba669
Autor:
Jeanne Palmer, Xiaoyu Chai, Paul J Martin, Daniel Weisdorf, Yoshihiro Inamoto, Joseph Pidala, Madan Jagasia, Steven Pavletic, Corey Cutler, Georgia Vogelsang, Sally Arai, Mary ED Flowers, Stephanie J Lee
Publikováno v:
Haematologica, Vol 100, Iss 5 (2015)
Failure-free survival, defined as the absence of relapse, non-relapse mortality or addition of another systemic therapy, has been proposed as a potential endpoint for clinical trials, but its use has only been reported for single-center studies. We m
Externí odkaz:
https://doaj.org/article/28b0547932104f39936d05a73d795238
Publikováno v:
PLoS Medicine, Vol 4, Iss 1, p e8 (2007)
BackgroundCurrent criteria for the selection of unrelated donors for hematopoietic cell transplantation (HCT) include matching for the alleles of each human leukocyte antigen (HLA) locus within the major histocompatibility complex (MHC). Graft-versus
Externí odkaz:
https://doaj.org/article/6d74be1c99d14d1c8cc6d157192e72fd
Autor:
Paul J Martin
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 33, Iss 4, Pp 255-256 (2011)
Externí odkaz:
https://doaj.org/article/67e39ad4ea6443ef8240459e3056d193
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Allogeneic hematopoietic cell transplantation (Allo-HCT) is a curative therapy for hematological malignancies (i.e., leukemia and lymphoma) due to the graft-versus-leukemia (GVL) activity mediated by alloreactive T cells that can eliminate residual m
Externí odkaz:
https://doaj.org/article/2f94a2e16ee74723af7f64c1cedb7a75
Autor:
Yoshihiro Inamoto, Stephanie J. Lee, Lynn E. Onstad, Mary E.D. Flowers, Betty K. Hamilton, Madan H. Jagasia, Paul J. Martin, Steven Z. Pavletic, Joseph A. Pidala, Iskra Pusic, Georgia B. Vogelsang, Daniel Wolff, Paul A. Carpenter
Publikováno v:
Blood Advances, Vol 4, Iss 1, Pp 40-46 (2020)
Abstract: Implementation of the 2014 National Institutes of Health (NIH) response algorithm for joint/fascia graft-versus-host disease (GVHD) has identified real-world limits to its application. To refine the 2014 NIH response algorithm, we analyzed
Externí odkaz:
https://doaj.org/article/7b061d43ccbe4b15999f4b8b96d6b960
Autor:
Zhihui Zhang, Wei Hong, Qian Wu, Spiridon Tsavachidis, Jian-rong Li, Christopher I. Amos, Chao Cheng, Sarah E. Sartain, Vahid Afshar-Kharghan, Jing-fei Dong, Pavan Bhatraju, Paul J. Martin, Robert S. Makar, Pavan K. Bendapudi, Ang Li
Publikováno v:
Thrombosis Research. 225:39-46
Autor:
Yoshihiro Inamoto, Jennifer White, Reiko Ito, Paul J. Martin, Giancarlo Fatobene, Ayumu Ito, Takashi Tanaka, Saiko Kurosawa, Sung-Won Kim, Merav Bar, Mohamed L. Sorror, Brenda M. Sandmaier, Stephanie J. Lee, Takahiro Fukuda, Mary E.D. Flowers
Publikováno v:
Blood Advances, Vol 3, Iss 18, Pp 2764-2777 (2019)
Although differences in the incidence of chronic graft-versus-host disease (GVHD) across the races have been suggested, these have not been systematically investigated. This study compared the incidence, sites, severity, and outcomes of late acute GV
Externí odkaz:
https://doaj.org/article/8d57778f27a945b6858cf847ad2ccdf7
Autor:
Garrett A. Perchetti, Melinda A. Biernacki, Hu Xie, Jared Castor, Laurel Joncas-Schronce, Masumi Ueda Oshima, YoungJun Kim, Keith R. Jerome, Brenda M. Sandmaier, Paul J. Martin, Michael Boeckh, Alexander L. Greninger, Danniel Zamora
Publikováno v:
Bone Marrow Transplantation. 58:430-436
Autor:
Damian J. Green, David G. Maloney, Barry E. Storer, Brenda M. Sandmaier, Leona A. Holmberg, Pamela S. Becker, Min Fang, Paul J. Martin, George E. Georges, Michelle E. Bouvier, Rainer Storb, Marco Mielcarek
Publikováno v:
Blood Advances, Vol 1, Iss 24, Pp 2247-2256 (2017)
Abstract: We evaluated tandem autologous/allogeneic hematopoietic cell transplantation followed by bortezomib maintenance therapy in a prospective phase 2 trial of treatment of high-risk multiple myeloma. The high-dose conditioning regimen for autolo
Externí odkaz:
https://doaj.org/article/488d366e6ddb479f9dd0b1f16361e44e